Robin V. Ward

2.6k citations

26 papers · 2.3k indexed · h-index 18

Impact in

Cancer Research top 1%
- Protease and Inhibitor Mechanisms
Immunology and Allergy top 2%
- Cell Adhesion Molecules Research

Papers in

Cancer Research 11
- Protease and Inhibitor Mechanisms 11
Biotechnology 4
- Enzyme Production and Characterization 4

Co-authors: Gillian Murphy Andrew Docherty John J. Reynolds Mark I. Cockett Susan J. Atkinson Davina E. OWEN David Howlett Ashley R. George
Journals: Biochemical Journal (10 papers)European Journal of Biochemistry (1 paper)Thorax (1 paper)Neurobiology of Aging (1 paper)Journal of Biological Chemistry (1 paper)
Partner nations: United Kingdom United States Japan

In The Last Decade

Robin V. Ward

25 papers receiving 2.2k citations

Peers

Countries citing papers authored by Robin V. Ward

Since Specialization

Citations

This map shows the geographic impact of Robin V. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin V. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin V. Ward more than expected).

Fields of papers citing papers by Robin V. Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin V. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin V. Ward. The network helps show where Robin V. Ward may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robin V. Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin V. Ward Line = papers co-authored together Robin V. Ward links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Extracellular matrix and matrix metalloproteinases in sciatic nerve Journal of Neuroscience Research ·Christopher I. Platt, Craig A. Krekoski, Robin V. Ward, Dylan R. Edwards, Jelena Gavrilović	2003	61
2	Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response European Journal of Biochemistry ·Carol W. Gray, Robin V. Ward, Eric Karran, Sandra Turconi, Alison Rowles, Dave DeMeulenaere, Christopher Southan, A.J.L. Barton, Dr Priyanka P. Shetty, Andrew B. West, Sarah Fernandes de Paula Cortezzi, Namir J. Hassan, HELEN E. CLINKENBEARD, Charles R. Hanning, Bernard Y. Amegadzie, John B. Davis, Colin Dingwall, George P. Livi, Caretha L. Creasy	2000	219
3	Expression, Purification, and Functional Analysis of the Human Serine Protease HtrA2 Protein Expression and Purification ·Sarah Fernandes de Paula Cortezzi, Paul S. Carter, Sandra Turconi, Gary Pettman, Eric Karran, Carol W. Gray, Robin V. Ward, Owen Jenkins, Caretha L. Creasy	2000	49
4	Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide Biochemical Journal ·Robin V. Ward, K.H. Jennings, Shuying Yang, W.A. Frankland, Davina E. OWEN, Kenya Haugen, Gary Christie, O. Lapina, Subbarayalu Arun Vijay, Eric Karran, David Howlett	2000	31
5	Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation. PubMed ·David Howlett, Ashley R. George, Davina E. OWEN, Robin V. Ward, Roger E. Markwell	1999	114
6	Biological activity associated with a high molecular weight form of β-amyloid. Lancaster EPrints (Lancaster University) ·David Howlett, Robin V. Ward, Letizia Bresciani, K.H. Jennings, Gary Christie, David Allsop, Carol W. Gray, Eric Karran	1999	2
7	Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer β-amyloid fibril formation Biochemical Journal ·David Howlett, Ashley R. George, Davina E. OWEN, Robin V. Ward, Roger E. Markwell	1999	45
8	Presenilins – in search of functionality Biochemical Society Transactions ·Eric Karran, David Allsop, Gary Christie, Janet L. Davis, Charles A. Gray, S. Schermer, Robin V. Ward	1998	6
9	Studies on inhibition of β-amyloid formation in APP-751-transfected IMR-32 cells, and SPA4CT-transfected SHSY5Y cells Lancaster EPrints (Lancaster University) ·David Allsop, G.S. Christie, Chi Cheung Poon, Sandra L. Holmes, Roger E. Markwell, David Owen, Layton H. Smith, Harry Wadsworth, Robin V. Ward, Tobias Hartmann, Stefan F. Lichtenthaler, Geneviève Evin, Steve Fuller, Judith Tanner, Colin L. Masters, Konrad Beyreuther, Nurizzati Hidayah Mohd Afendi	1997	2
10	Presenilin–1 is Processed into Two Major Cleavage Products in Neuronal Cell Lines PubMed ·Robin V. Ward, John B. Davis, Carol W. Gray, A.J.L. Barton, Laura G. Bresciani, Matilde Caivano, 浩一浅野, Karen Duff, David Loría Araujo, John Hardy, Gareth W. Roberts, Eric Karran	1996	26
11	Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses Biochemical Journal ·Noboru Fujimoto, Robin V. Ward, Takashi Shinya, Kazushi Iwata, Kyoko Yamashita, Taro Hayakawa	1996	17
12	588 Studies on inhibition of βA4 formation in APP-751 transfected IMR-32 cells, and SPA4CT transfected SHSYSY cells Neurobiology of Aging ·David Allsop, G.S. Christie, Chi Cheung Poon, Sandra L. Holmes, Roger E. Markwell, David Owen, Layton H. Smith, Harry Wadsworth, Robin V. Ward, Tobias Hartmann, Stefan F. Lichtenthaler, Geneviève Evin, Steve Fuller, Colin L. Masters, Konrad Beyreuther, Nurizzati Hidayah Mohd Afendi	1996	0
13	Intermolecular Autolytic Cleavage Can Contribute to the Activation of Progelatinase A by Cell Membranes Journal of Biological Chemistry ·Susan J. Atkinson, Thomas Crabbe, Shengyang Jin, Robin V. Ward, Michael J. Butler, Hiroshi Sato, Motoharu Seiki, John J. Reynolds, Gillian Murphy	1995	217
14	Interaction between Progelatinase A and TIMP‐2 Annals of the New York Academy of Sciences ·Taro Hayakawa, Noboru Fujimoto, Robin V. Ward, Kazushi Iwata	1994	1
15	Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases Biochemical Journal ·Susan J. Atkinson, Robin V. Ward, John J. Reynolds, Gillian Murphy	1992	29
16	Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Robin V. Ward, Susan J. Atkinson, Patrick M. Slocombe, Andrew Docherty, John J. Reynolds, Gillian Murphy	1991	187
17	The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 Biochemical Journal ·Robin V. Ward, Rosalind M. Hembry, John J. Reynolds, Gillian Murphy	1991	149
18	Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: Evidence that breakdown is mediated by metal loproteinases Journal of Periodontal Research ·Murray C. Meikle, Susan J. Atkinson, Robin V. Ward, Gillian Murphy, John J. Reynolds	1989	128
19	Tissue inhibitor of metalloproteinases and collagenase inhibitory activity in lung secretions from patients with chronic obstructive bronchitis: effect of corticosteroid treatment. Thorax ·David Burnett, John J. Reynolds, Robin V. Ward, Simon C. Afford, Robert A. Stockley	1986	13
20	A fibrosarcoma model derived from mouse embryo cells: Growth properties and secretion of collagenase and metalloproteinase inhibitor (TIMP) by tumour cell lines International Journal of Cancer ·三浦四郎衛, Robin V. Ward, John J. Reynolds	1984	62

About Robin V. Ward

Robin V. Ward is a scholar working on Cancer Research, Biotechnology, Hematology, Immunology and Allergy and Oncology, having authored 26 papers that have together received 2.3k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (11 papers), Alzheimer's disease research and treatments (7 papers), Peptidase Inhibition and Analysis (7 papers), Computational Drug Discovery Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Enzyme Production and Characterization (4 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Cancer Research (1.2k citations), Immunology and Allergy (302 citations), Hematology (521 citations), Oncology (769 citations) and Periodontics (104 citations). Robin V. Ward has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Gillian Murphy, Andrew Docherty, John J. Reynolds, Mark I. Cockett, Susan J. Atkinson, Davina E. OWEN, David Howlett, Ashley R. George, Roger E. Markwell and Frances Willenbrock. Their work appears in journals such as Biochemical Journal, European Journal of Biochemistry, Thorax, Neurobiology of Aging and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact